SPECIALIST DEVELOPMENT & COMMERCIALIZATION
Proprietary ingredient development & commercialization
PCG works with brands and ingredient suppliers to turn a differentiated ingredient idea into a development program. The scope can connect material or delivery innovation, consumer-product applications, sourcing, an evidence plan and commercial positioning.
DEFINE THE WORK. RESOLVE THE DECISIONS.
Define the technical difference
Write down the starting material, proposed variant or delivery approach, intended application and comparison that would demonstrate value. Separate what is already established from what needs characterization or research. A compelling name should follow a credible technical proposition.
Build applications and evidence together
A supplier’s ingredient may need different formulation and evaluation work for powders, liquids, gummies or topical applications. PCG can coordinate application briefs and research questions with appropriate partners. Evidence for one material, serving or format should not be generalized automatically to every finished product.
Set ownership and commercialization terms early
Agree the rights to background know-how, new work, test data, naming, licensing and manufacturing access with counsel. Define responsibilities for supplier qualification and future changes. Contractual rights, trademarks, trade secrets and patents address different needs and should not be described as a guaranteed permanent monopoly.
What the engagement can deliver
- Ingredient opportunity and technical-development brief
- Application prototype and sourcing scope
- Characterization and substantiation roadmap
- Commercial rights and branding questions for counsel
These are scoping options, not a fixed package. Deliverables, milestones, testing, rights and exclusions are agreed before work begins.
Discuss your project ↗A clear scope and commercial model
PCG is a development and coordination partner. The selected CDMO performs manufacturing; qualified research and testing partners execute specialist work as agreed. Client fees apply to development and portfolio engagements below $50 million in annual revenue. Eligible engagements above $50 million can be client-fee-free with CDMO compensation under agreed terms. Research is separately quoted at market rates; production and testing are not implied to be free. At exactly $50 million, confirm the model with PCG.
Scope, compensation and ownership questions ↗Useful next steps